Alx Oncology Holdings (ALXO) Other Accumulated Expenses (2019 - 2026)

Alx Oncology Holdings' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 4535.42% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 4535.42% YoY), while the FY2025 annual figure was $2.3 million, down 9.72% from the prior year.
• Other Accumulated Expenses came in at $2.2 million for Q1 2026 at Alx Oncology Holdings, down from $2.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.6 million in Q4 2024 to a low of $40000.0 in Q2 2025.
• A 5-year average of $1.5 million and a median of $1.8 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses sank 98.35% in 2025 and soared 4535.42% in 2026, its largest moves.
• Alx Oncology Holdings' Other Accumulated Expenses stood at $1.6 million in 2022, then sank by 67.09% to $543000.0 in 2023, then soared by 373.85% to $2.6 million in 2024, then retreated by 9.72% to $2.3 million in 2025, then retreated by 4.22% to $2.2 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.2 million, $2.3 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison